Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Farxiga (dapagliflozin) and Jardiance (empagliflozin) are both SGLT2 inhibitors used to manage Type 2 diabetes. While both medications work similarly, there are some differences between them. Unlike Jardiance, Farxiga is safe for use in children ages 10 years and older. Farxiga is not recommended during the second and third trimesters of pregnancy, and Jardiance must be paused before certain surgeries. Common side effects of Jardiance include high cholesterol, which was not reported with Farxiga. Serious side effects can happen with both medication; however only Jardiance has a risk of leg and foot amputations.
Farxiga (dapagliflozin)
Jardiance (empagliflozin)
Farxiga (dapagliflozin)
Jardiance (empagliflozin)
Summary of Farxiga vs. Jardiance
Summary for SGLT2 inhibitor
Prescription only
Farxiga, the brand name for dapagliflozin, is used together with a nutritious diet and exercise plan to lower blood sugar levels in people 10 years and older with Type 2 diabetes. It can also help lower the risk of serious complications, hospitalization, and death in certain adults with heart failure or chronic kidney disease (CKD). Farxiga (dapagliflozin) belongs to the drug class called sodium-glucose cotransporter 2 (SGLT2) inhibitors. It's taken by mouth once a day. Some side effects include yeast infections, urinating more often, and weight loss.
•Type 2 diabetes (in addition to diet and exercise) in people age 10 and over
•Lowering the risk of hospitalization for heart failure in adults with Type 2 diabetes and heart disease
•Lowering the risk of hospitalization and death due to heart problems in people with heart failure
•Lowering the risk of worsening kidney problems, hospitalization for heart failure, and death due to heart problems in adults with chronic kidney disease (CKD)
Indications for
•Type 2 diabetes (in addition to diet and exercise) in people age 10 years and older
•Lowering the risk of death due to heart problems in adults with Type 2 diabetes and heart disease
•Lowering the risk of hospitalization and death due to heart problems in adults with heart failure
•Lowering the risk of worsening kidney problems, hospitalization, and death due to heart problems in adults with chronic kidney disease (CKD)
Pros and Cons of Farxiga vs. Jardiance
Pros and Const for SGLT2 inhibitor
Pros
•Taken only once daily
•Low risk of causing low blood sugar when taken by itself